Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY
Publication
, Journal Article
Patel, MR; Fox, KAA; Califf, RM
Published in: NEW ENGLAND JOURNAL OF MEDICINE
2011
Duke Scholars
Published In
NEW ENGLAND JOURNAL OF MEDICINE
ISSN
0028-4793
Publication Date
2011
Volume
365
Issue
24
Start / End Page
2335 / 2335
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, M. R., Fox, K. A. A., & Califf, R. M. (2011). Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 365(24), 2335–2335.
Patel, Manesh R., Keith A. A. Fox, and Robert M. Califf. “Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY.” NEW ENGLAND JOURNAL OF MEDICINE 365, no. 24 (2011): 2335–2335.
Patel MR, Fox KAA, Califf RM. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE. 2011;365(24):2335–2335.
Patel, Manesh R., et al. “Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY.” NEW ENGLAND JOURNAL OF MEDICINE, vol. 365, no. 24, 2011, pp. 2335–2335.
Patel MR, Fox KAA, Califf RM. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE. 2011;365(24):2335–2335.
Published In
NEW ENGLAND JOURNAL OF MEDICINE
ISSN
0028-4793
Publication Date
2011
Volume
365
Issue
24
Start / End Page
2335 / 2335
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences